A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening) (NCT06948422)
A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)
🩺 Plain-English Summary (8th-Grade Level)
The GZPL master protocol will support 2 independent studies, J2A-MC-GZL1 (GZL1) and J2A-MC-GZL2 (GZL2). The purpose of this study is to create a framework to evaluate the safety and efficacy of orforglipron for the treatment of hypertension in participants with obesity or overweight.
Who can join: Review the eligibility criteria below.
Location: Elite Clinical Studies, LLC — Phoenix, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (100 Sites)
Showing the first 25 of 100 sites.
- Elite Clinical Studies, LLC — Phoenix, Arizona
- Valley Clinical Trials, Inc. — Covina, California
- Valley Clinical Trials, Inc. — Northridge, California
- Chase Medical Research, LLC — Waterbury, Connecticut
- Excel Medical Clinical Trials — Boca Raton, Florida
- Care Access - Brandon — Brandon, Florida
- Northeast Research Institute - Downtown Office — Jacksonville, Florida
- Care Access - St. Petersburg — St. Petersburg, Florida
- East-West Medical Research Institute — Honolulu, Hawaii
- Sinai Hospital Of Baltimore — Baltimore, Maryland
- Ascension Saint Agnes Heart Care — Baltimore, Maryland
- Lucida Clinical Trials — New Bedford, Massachusetts
- Arcturus Healthcare , PLC, Troy Internal Medicine Research Division — Troy, Michigan
- StudyMetrix Research — City of Saint Peters, Missouri
- Excel Clinical Research, LLC — Las Vegas, Nevada
- Palm Research Center Sunset — Las Vegas, Nevada
- Rochester Clinical Research, LLC — Rochester, New York
- Remington-Davis, Inc — Columbus, Ohio
- PriMED Clinical Research — Dayton, Ohio
- Advanced Research Institute - Tigard — Tigard, Oregon
- Care Access - Mauldin — Mauldin, South Carolina
- Dallas Heart and Vascular Consultants, PA — Duncanville, Texas
- Texas Institute of Cardiology, PA — McKinney, Texas
- North Hills Family Medicine/North Hills Medical Research — North Richland Hills, Texas
- Advanced Research Institute — Ogden, Utah
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hypertension
- Implementing a Home Blood Pressure Monitoring Program in Primary Care — New York, New York
- SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN — Birmingham, Alabama
- Stress and Blood Pressure Management for Caregivers — Columbus, Ohio
- Caveolin-1 and Vascular Dysfunction — Boston, Massachusetts
- The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension — Birmingham, Alabama
- Skills-Based Educational Strategies for Reduction of Vascular Events in Orange County — Irvine, California
Explore by condition: All Hypertension clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.